Deutsche Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $276M | Sell |
|
|||||
|
2025
Q2 | $212M | Buy |
|
|||||
|
2025
Q1 | $156M | Buy |
|
|||||
|
2024
Q4 | $131M | Buy |
|
|||||
|
2024
Q3 | $148M | Buy |
|
|||||
|
2024
Q2 | $119M | Sell |
|
|||||
|
2024
Q1 | $75.8M | Buy |
|
|||||
|
2023
Q4 | $88.5M | Sell |
|
|||||
|
2023
Q3 | $82M | Sell |
|
|||||
|
2023
Q2 | $92.5M | Buy |
|
|||||
|
2023
Q1 | $92.1M | Sell |
|
|||||
|
2022
Q4 | $111M | Buy |
|
|||||
|
2022
Q3 | $50.8M | Buy |
|
|||||
|
2022
Q2 | $36.1M | Sell |
|
|||||
|
2022
Q1 | $46.1M | Buy |
|
|||||
|
2021
Q4 | $46.6M | Sell |
|
|||||
|
2021
Q3 | $53.3M | Buy |
|
|||||
|
2021
Q2 | $44.9M | Buy |
|
|||||
|
2021
Q1 | $36.5M | Sell |
|
|||||
|
2020
Q4 | $38.1M | Buy |
|
|||||
|
2020
Q3 | $41.9M | Buy |
|
|||||
|
2020
Q2 | $42.4M | Sell |
|
|||||
|
2020
Q1 | $31.9M | Buy |
|
|||||
|
2019
Q4 | $32.4M | Sell |
|
|||||
|
2019
Q3 | $52.7M | Sell |
|
|||||
|
2019
Q2 | $54.9M | Buy |
|
|||||
|
2019
Q1 | $42.6M | Buy |
|
|||||
|
2018
Q4 | $14.6M | Sell |
|
|||||
|
2018
Q3 | $26.7M | Sell |
|
|||||
|
2018
Q2 | $53.7M | Buy |
|
|||||
|
2018
Q1 | $53.2M | Buy |
|
|||||
|
2017
Q4 | $26.8M | Buy |
|
|||||
|
2017
Q3 | $20.4M | Sell |
|
|||||
|
2017
Q2 | $15.3M | Sell |
|
|||||
|
2017
Q1 | $10.7M | Sell |
|
|||||
|
2016
Q4 | $12M | Sell |
|
|||||
|
2016
Q3 | $26.9M | Buy |
|
|||||
|
2016
Q2 | $21.8M | Buy |
|
|||||
|
2016
Q1 | $19M | Buy |
|
|||||
|
2015
Q4 | $25.1M | Sell |
|
|||||
|
2015
Q3 | $30.4M | Sell |
|
|||||
|
2015
Q2 | $47.6M | Buy |
|
|||||
|
2015
Q1 | $29.4M | Buy |
|
|||||
|
2014
Q4 | $20.4M | Buy |
|
|||||
|
2014
Q3 | $13.7M | Buy |
|
|||||
|
2014
Q2 | $10.6M | Sell |
|
|||||
|
2014
Q1 | $17.1M | Buy |
|
|||||
|
2013
Q4 | $7.31M | Sell |
|
|||||
|
2013
Q3 | $10.7M | Buy |
|
|||||
|
2013
Q2 | $3.05M | Buy |
|